HR Pharma has filed for a prescription to OTC switch for Opill, a decades-old daily progestin-only pill, just a few weeks after its $2 billion takeover by Ireland-headquartered Perrigo was completed.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback